Stock Analiz

Rocket Pharmaceuticals, Inc. (RCKT) stock forecast and price target

Price $2.30 · data as of November 13, 2026

12-month price target

Average target$8.82
Upside / downside+283.4%
Analysts11
ConsensusBuy
Low $4.00Average $8.82High $15.00

Gold marker: average target · white marker: today’s price ($2.30)

Analyst ratings

Strong buy 1Buy 6Hold 6Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.12+94.2%$920780
Next fiscal year
ends December 31, 2027
$-1.57−1265.2%$12M
Next quarter
ends December 31, 2026
$-0.42−11.0%$763440
Quarter after
ends March 31, 2027
$-0.41+1.6%$3M

Consensus of the analysts covering Rocket Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Rocket Pharmaceuticals stock price target?

The average 12-month target from 11 analysts is $8.82, 283.4% above the current price of $2.30 Targets range from $4.00 to $15.00.

Is Rocket Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 6 buy, 6 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Rocket Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.12 for the fiscal year ending December 31, 2026 and $-1.57 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.